Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools

Molecular Biology Reports

Volumn 41, Issue 12, 2014, Pages 8127-8135

  Canturk, Kemal Murat ^a,b   Ozdemir, Muhsin ^b   Can, Cavit ^b   Öner, Setenay ^b   Emre, Ramazan ^a   Aslan, Huseyin ^b   Cilingir, Oguz ^b   Ciftci, Evrim ^b   Celayir, Fatih Mehmet ^c   Aldemir, Ozgur ^d   Özen, Mustafa ^e   Artan, Sevilhan ^b  

^a Ministry of Justice Department of Biology Council of Forensic Medicine ^*  (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^c Bursa evket Yilmaz Hospital   (Turkey)

^d MUSTAFA KEMAL UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bioinformation; Bladder cancer; CDK4; CDK6; KEGG pathways; miRNA

Indexed keywords

CYCLIN DEPENDENT KINASE 8; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MICRORNA; MICRORNA 125B; MICRORNA 141; MICRORNA 195; MICRORNA 23B; MICRORNA 26A; MICRORNA LET 7C; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN; RNA; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; CDK4 PROTEIN, HUMAN; CDK6 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6;

ADULT; AGED; ARTICLE; BCL2 GENE; BIOINFORMATICS; BLADDER CANCER; CDK6 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; E2F3 GENE; ERBB3 GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; ONCOGENE; ONCOGENE MYC; PTEN GENE; QUANTITATIVE ANALYSIS; RB GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; BIOLOGY; BLADDER TUMOR; COMPUTER PROGRAM; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION STUDY; GENETICS; PATHOLOGY; PROCEDURES;

COMPUTATIONAL BIOLOGY; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; HUMANS; MICRORNAS; SOFTWARE; URINARY BLADDER NEOPLASMS;

EID: 84926678603     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3713-5     Document Type: Article

References (30)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC cancerbase No. 11 Lyon, France: international agency for research on cancer. Available from: http://globocan.iarc.fr, accessed on 04/06/2014.
2. Taioli E, Raimondi S (2005) Genetic susceptibility to bladder cancer. Lancet 366:610–612
3. Clapp RW, Jacobs MM, Loechler EL (2008) Environmental and occupational causes of cancer: new evidence 2005-2007. Rev Environ Health 23:1–37
4. Garzon R, Marcucci G, Croce CM (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9:775–789
5. http://www.mirbase.org/index.shtml
6. Visone R, Croce CM (2009) MiRNAs and cancer. Am J Pathol 174:1131
7. Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269
8. Chen YH et al (2013) Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing. Urol Oncol 31:219–227
9. Dyrskjøt L et al (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69:4851–4860
10. Han Y et al (2011) MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE 6:e18286
11. Puerta-Gil P, Garcia-Baquero R, Jia AY, Ocana S, Alvarez-Mugica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sanchez-Carbayo M (2012) miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol 180:1808–1815
12. Rosenberg E, Baniel J, Spector Y, Faerman A, Meiri E, Aharonov R, Margel D, Goren Y, Nativ O (2013) Predicting progression of bladder urothelial carcinoma using microRNA expression. BJU Int 112(7):1027–1034
13. Wang S, Hu J, Zhang D, Li J, Fei Q, Sun Y (2014) Prognostic role of microRNA-31 in various cancers: a meta-analysis.Tumour Biol. [Epub ahead of print]
14. Fu W, Pang L, Chen Y, Yang L, Zhu J, Wei Y (2014) The MicroRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis. Sci World J. 2014: 523979. Epub 2014 Jul 6. Review.
15. Vergoulis T, Vlachos IS, Alexiou P,, Georgakilas G,, Maragkakis M, Reczko M, Gerangelos S, Koziris N, Dalamagas T, Hatzigeorgiou AG (2012) Tarbase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucl Acids Res 40(D1):D222–D229. doi:10.1093/nar/gkr1161
16. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD, Prionidis K, Dalamagas T, Hatzigeorgiou AG (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways nucleic acids research (Web server issue)
17. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504
18. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289–300
19. Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M (2013) Enokida H (2013) Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol 10(7):396–404. doi:10.1038/nrurol.2013.113.Epub.Review
20. Guancial EA, Bellmunt J, Yeh S, Rosenberg JE, Berman DM (2014) The evolving understanding of microRNA in bladder cancer. UrolOncol 32(1):e31–e40. doi:10.1016/j.urolonc.2013.04.014 Epub 2013 Aug 2
21. http://www.kegg.jp/kegg-bin/search_pathway_text?map=map&keyword=cancer&mode=1&viewImage=true
22. Abdollahi A, Schwager C, Kleeff J, Esposito I, Domhan S, Peschke P, Hauser K, Hahnfeldt P, Hlatky L, Debus J, Peters JM, Friess H, Folkman J, Huber PE (2007) Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci USA 104(31):12890–12895 Epub 2007 Jul 24
23. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, Febbo PG, Kornblum HI, Cloughesy TF, Nelson SF, Mischel PS (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 103(46):17402–17407 Epub 2006 Nov 7
24. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C (2010) Molecular pathways of urothelial development and bladder tumorigenesis. UrolOncol 28(4): 401–8. doi: 10.1016/j.urolonc.2009.04.019. Review.
25. Sfakianos JP, Lin Gellert L, Maschino A, Gotto GT, Kim PH, Al-Ahmadie H, Bochner BH (2014) The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. UrolOncol S1078–1439(14):00034–00039. doi:10.1016/j.urolonc.2014.02.003 Epub ahead of print
26. Olsson AY, Feber A, Edwards S, TePoele R, Giddings I, Merson S, Cooper CS (2007) Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene 26(7):1028–1037 Epub 2006 Aug 14
27. Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, Dong W, Huang J, Lin T (2011) MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 128(8):1758–1769. doi:10.1002/ijc.25509
28. Wu XR (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5(9):713–725
29. Wang G, Zheng L, Yu Z, Liao G, Lu L, Xu R, Zhao Z, Chen G (2012) Increased cyclin-dependent kinase 6 expression in bladder cancer. Oncol Lett 4(1):43–46 Epub 2012 Apr 25
30. Lin Y, Wu J, Chen H, Mao Y, Liu Y, Mao Q, Yang K, Zheng X, Xie L (2012) Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBS Lett 586(4):442–447. doi:10.1016/j.febslet.2012.01.027 Epub